Clinical characteristics of 18 E/R-positive relapse cases that were analyzed with SNP arrays
| Patient ID . | Sex . | Age, y . | Remission, mo . | Relapse site . | MRD . | Outcome, mo . | Source . |
|---|---|---|---|---|---|---|---|
| 1 | Male | 3.7 | 46 | BM | NA | SCT, relapse,* | Germany |
| 2 | Male | 4.2 | 51 | BM | NA | SCT, remission 96 | Germany |
| 3 | Male | 2.3 | 19 | BM | NA | SCT, relapse* | Austria |
| 4 | Male | 3.7 | 78 | BM | IR | SCT* | Austria |
| 5 | Male | 4.3 | 50 | BM | LR | Remission 126 | Austria |
| 6 | Male | 3.4 | 16 | BM | IR | SCT, remission 86 | Austria |
| 7 | Male | 2.1 | 43 | BM | NA | SCT, remission 78 | Austria |
| 8 | Male | 4.7 | 40 | BM | NA | Remission 21 | Austria |
| 9 | Female | 3.6 | 32 | BM | IR | SCT, remission 23 | Austria |
| 10 | Male | 9.3 | 29 | BM | IR | SCT, relapse, remission 26 | Austria |
| 11 | Male | 3.3 | 79 | Testis | IR | SCT, remission 69 | Austria |
| 12 | Male | NA | NA | BM | NA | NA | St Jude #48 |
| 13 | Female | NA | NA | BM | NA | NA | St Jude #49 |
| 14 | Male | 3.2 | 68 | BM | LR | Remission 14 | Germany |
| 15 | Male | 4.5 | 27 | BM | IR | Remission 35 | Germany |
| 16 | Male | NA | NA | BM | NA | NA | St Jude #10 |
| 17 | Male | NA | NA | BM | NA | NA | St Jude #44 |
| 18 | Female | NA | NA | BM | NA | NA | St Jude #50 |
| Patient ID . | Sex . | Age, y . | Remission, mo . | Relapse site . | MRD . | Outcome, mo . | Source . |
|---|---|---|---|---|---|---|---|
| 1 | Male | 3.7 | 46 | BM | NA | SCT, relapse,* | Germany |
| 2 | Male | 4.2 | 51 | BM | NA | SCT, remission 96 | Germany |
| 3 | Male | 2.3 | 19 | BM | NA | SCT, relapse* | Austria |
| 4 | Male | 3.7 | 78 | BM | IR | SCT* | Austria |
| 5 | Male | 4.3 | 50 | BM | LR | Remission 126 | Austria |
| 6 | Male | 3.4 | 16 | BM | IR | SCT, remission 86 | Austria |
| 7 | Male | 2.1 | 43 | BM | NA | SCT, remission 78 | Austria |
| 8 | Male | 4.7 | 40 | BM | NA | Remission 21 | Austria |
| 9 | Female | 3.6 | 32 | BM | IR | SCT, remission 23 | Austria |
| 10 | Male | 9.3 | 29 | BM | IR | SCT, relapse, remission 26 | Austria |
| 11 | Male | 3.3 | 79 | Testis | IR | SCT, remission 69 | Austria |
| 12 | Male | NA | NA | BM | NA | NA | St Jude #48 |
| 13 | Female | NA | NA | BM | NA | NA | St Jude #49 |
| 14 | Male | 3.2 | 68 | BM | LR | Remission 14 | Germany |
| 15 | Male | 4.5 | 27 | BM | IR | Remission 35 | Germany |
| 16 | Male | NA | NA | BM | NA | NA | St Jude #10 |
| 17 | Male | NA | NA | BM | NA | NA | St Jude #44 |
| 18 | Female | NA | NA | BM | NA | NA | St Jude #50 |
MRD indicates minimal residual disease; NA, not available; SCT, hematopoietic stem cell transplantation; IR, intermediate risk; and LR, low risk.
Death.